In vivo investigation demonstrated that GLP-1 receptor agonism with exenatide was able to reduce CSF secretion and ICP by at least 45% [16]
As Parv says in the video (summarised): GLP-1 patches are not what they say they are
Evidence from human studies suggests that dietary or supplemental zinc can have antidepressant effects, providing a promising adjunctive treatment approach for individuals who do not fully respond to conventional antidepressant therapy [506,507,508]
Genetic testing potentially identifying optimal responders though not currently standard practice for peptide protocols
Poria cocos, in particular, has shown efficacy in improving AKI caused by increased fluid accumulation in SAP [18, 46, 121]
The proof-of-concept study was the first of its kind to demonstrate a noninvasive, self-administered therapy that has potential for boosting glutathione levels in the brain